Bernhard Hoffmann
Corporate Officer/Principal chez OCUPHIRE PHARMA, INC.
Fortune : 165 382 $ au 30/04/2024
Profil
Bernhard Hoffmann's current job(s) include Vice President-Corporate Development & Finance at OcuSub, Inc. and Senior Vice President-Corporate Development at Ocuphire Pharma, Inc. Mr. Hoffmann's former job(s) include Director at Prudential Vector Healthcare Group from 1996 to 2001, and CFO, MD-Investment Banking & Partner at EHS Securities LLC from 2001 to 2003.
Mr. Hoffmann's education history includes an undergraduate degree from Dartmouth College and an MBA from Tuck School of Business at Dartmouth.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
OCUPHIRE PHARMA, INC.
0,43% | 15/04/2024 | 107 741 ( 0,43% ) | 165 382 $ | 30/04/2024 |
Postes actifs de Bernhard Hoffmann
Sociétés | Poste | Début |
---|---|---|
OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | - |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Directeur Financier/CFO | 01/02/2018 |
Anciens postes connus de Bernhard Hoffmann
Sociétés | Poste | Fin |
---|---|---|
EHS Securities LLC | Directeur Financier/CFO | 01/01/2003 |
Prudential Vector Healthcare Group | Directeur/Membre du Conseil | 01/01/2001 |
Formation de Bernhard Hoffmann
Dartmouth College | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
EHS Securities LLC | |
Prudential Vector Healthcare Group | Finance |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |